Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?
- PMID: 29373092
- DOI: 10.1200/JCO.2017.76.9802
Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?
Comment on
-
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.J Clin Oncol. 2018 Mar 10;36(8):735-740. doi: 10.1200/JCO.2017.74.6586. Epub 2018 Jan 25. J Clin Oncol. 2018. PMID: 29369732
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
